Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
169.59
+1.63 (0.97%)
Apr 3, 2025, 1:44 PM EDT - Market open
Quest Diagnostics Revenue
In the year 2024, Quest Diagnostics had annual revenue of $9.87B with 6.70% growth. Quest Diagnostics had revenue of $2.62B in the quarter ending December 31, 2024, with 14.55% growth.
Revenue (ttm)
$9.87B
Revenue Growth
+6.70%
P/S Ratio
1.89
Revenue / Employee
$176,286
Employees
56,000
Market Cap
18.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
DGX News
- 1 day ago - Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening - PRNewsWire
- 1 day ago - Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025 - PRNewsWire
- 15 days ago - Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day - PRNewsWire
- 16 days ago - Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI - PRNewsWire
- 5 weeks ago - Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics - PRNewsWire
- 6 weeks ago - Quest Diagnostics to Host Investor Day on March 19, 2025 - PRNewsWire
- 7 weeks ago - GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System - PRNewsWire
- 2 months ago - Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year - PRNewsWire